Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after infection

葡萄牙 SARS-CoV-2 纵向血清流行率及感染后 12 个月抗体维持情况

阅读:5
作者:Luísa Canto E Castro, Andreia Gomes, Marta Serrano, Ana Helena Guia Pereira, Rita Ribeiro, Patrícia Napoleão, Inês Domingues, Cláudia Silva, Júlia Fanczal, Ângela Afonso, Andreia Lopes, Ionela Toader, Maria José Rego de Sousa, José Germano Rego de Sousa, Germano de Sousa, Maria M Mota, Bruno Silva-S

Abstract

During the COVID-19 pandemic, Portugal has experienced three distinct SARS-CoV-2 infection waves. We previously documented the prevalence of SARS-CoV-2 immunity, measured by specific antibodies, in September 2020, 6 months after the initial moderate wave. Here, we show the seroprevalence changes 6 months later, up to the second week of March 2021, shortly following the third wave, which was one of the most severe in the world, and 2 months following the start of the vaccination campaign. A longitudinal epidemiological study was conducted, with a stratified quota sample of the Portuguese population. Serological testing was performed, including ELISA determination of antibody class and titers. The proportion of seropositives, which was 2.2% in September 2020, rose sharply to 17.3% (95% CI: 15.8-18.8%) in March 2021. Importantly, circulating IgG and IgA antibody levels were very stable 6 months after the initial determination and up to a year after initial infection, indicating long-lasting infection immunity against SARS-CoV-2. Moreover, vaccinated people had higher IgG levels from 3 weeks post-vaccination when compared with previously infected people at the same time post-infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。